Profil
John Koconis formerly worked at Leo Pharma, Inc., as President & Chief Executive Officer from 1998 to 2014, Timber Pharmaceuticals LLC, as Chief Executive Officer from 2019 to 2020, Timber Pharmaceuticals, Inc., as Chairman, President & Chief Executive Officer from 2021 to 2024, Abbott Laboratories, as Principal, Genzyme Corp., as Head-Global Dermatology & Respiratory in 2016, LEO Pharma A, as Manager-International Marketing, Genzyme Therapeutics Ltd., as Head-Global Dermatology & Respiratory, and Castle Creek Biosciences, Inc., as Chief Commercial Officer & Executive VP from 2016 to 2019.
Mr. Koconis received his undergraduate degree in 1992 from Loyola University of Chicago and Masters Business Admin degree in 1996 from Quinlan School of Business.
Anciens postes connus de John Koconis
| Sociétés | Poste | Fin |
|---|---|---|
| TREX WIND-DOWN, INC. | Directeur Général | 22/01/2024 |
Timber Pharmaceuticals LLC
Timber Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Directeur Général | 01/04/2020 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Corporate Officer/Principal | 01/01/2019 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/07/2016 |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Directeur Général | 01/01/2014 |
Formation de John Koconis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Wholesales drugs and sundries | Retail Trade |
Quinlan School of Business
Quinlan School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Timber Pharmaceuticals LLC
Timber Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical services | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes therapies for treatment of orphan dermatologic diseases | Health Technology |
















